Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hA-MSC for Lupus Nephritis
NCT04318600Phase 1Completed
- Sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
- Start
- Jan 2014
- Primary completion
- Mar 2017
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label trial of human amniotic mesenchymal stem cells in lupus nephritis (LN) (2 arms), sponsored by Yan'an Affiliated Hospital of Kunming Medical University. Primary endpoint: Incidence of Adverse Events at 60 weeks. Started Jan 2014; status: completed.
02
Drugs
human amniotic mesenchymal stem cells
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT04318600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04318600.